Veru Inc. (VERU:NASDAQ) shot up at $14.95, a gain of 49.4%. On Wed, Apr 13, 2022, VERU:NASDAQ touched a New 2-Week High of $14.3. The stock appeared on our News Catalysts scanner on Thu, Apr 14, 2022 at 11:04 AM in the 'BIOTECH' category. From Wed, Mar 30, 2022, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Apr 11, 2022 at $14.57 with a volume of 339M+.
About Veru Inc. (VERU:NASDAQ)
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
Top 10 Gainers:
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 69.23%
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 68.6%
- Veru Inc. (VERU:NASDAQ), 49.35%
- Antares Pharma, Inc. (ATRS:NASDAQ), 48.66%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 46.24%
- Houston American Energy Corp. (HUSA:NYSEMKT), 42.94%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 40.63%
- HighPeak Energy Inc. (HPK:NASDAQ), 39.76%
- Creatd Inc. (CRTD:NASDAQ), 39.43%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 38.54%